Related references
Note: Only part of the references are listed.Impact of Factors Affecting the Residual Tumor Size Diagnosed by MRI Following Neoadjuvant Chemotherapy in Comparison to Pathology
Jeon-Hor Chen et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MRI Staging After Neoadjuvant Chemotherapy for Breast Cancer: Does Tumor Biology Affect Accuracy?
Kandace P. McGuire et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Accuracy of Breast Magnetic Resonance Imaging in Predicting Pathologic Response in Patients Treated With Neoadjuvant Chemotherapy
Jennifer De Los Santos et al.
CLINICAL BREAST CANCER (2011)
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
Claudette E. Loo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Accuracy of MRI in Prediction of Pathologic Complete Remission in Breast Cancer After Preoperative Therapy: A Meta-Analysis
Ying Yuan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
MRI-Model to Guide the Surgical Treatment in Breast Cancer Patients After Neoadjuvant Chemotherapy
Marieke E. Straver et al.
ANNALS OF SURGERY (2010)
Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging-Comparison with Contrast-enhanced MR Imaging and Pathologic Findings
Reiko Woodhams et al.
RADIOLOGY (2010)
Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)
Masafumi Kurosumi et al.
BREAST CANCER (2008)
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy
V Londero et al.
EUROPEAN RADIOLOGY (2004)
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy
SC Partridge et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2002)
Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
JA van der Hage et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
